|
|
Article: FDA approved Xolegel Gel for the treatment of seborrheic dermatitis.(PIPELINE PREVIEWS)
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- October 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Barrier Therapeutics, Inc, recently announced that the FDA has approved its product, Xolegel Gel 2% for the treatment of seborrheic dermatitis. Xolegel Gel 2% is a formulation of topical 2% ketoconazole. This formulation is a waterless gel that is approved ...
Related newspaper, magazine, and journal articles:
|
|
Article: Etiopathogenesis of seborrheic dermatitis
Indian Journal of Dermatology, Venereology and Leprology;
July 1, 2006 ;
700+ words
...Seborrheic dermatitis (SD) is a common inflammatory ... of the etiopathogenesis of seborrheic dermatitis. This should eventually lead ... of the disease. Seborrhea Seborrheic dermatitis is not a disorder of sebaceous ...
|
|